Literature DB >> 17055515

Should we consider gestational diabetes a vascular risk factor?

S Bo1, S Valpreda, G Menato, C Bardelli, C Botto, R Gambino, C Rabbia, M Durazzo, M Cassader, M Massobrio, G Pagano.   

Abstract

Few and contrasting data have reported vascular endothelial dysfunction and increased serum levels of endothelial dysfunction and inflammatory markers in women with previous gestational diabetes mellitus (pGDM). We aimed at evaluating 6.5 years after delivery: intimal medial thickness (IMT), and C-reactive protein (CRP), interleukin-6 (IL-6), E-selectin, intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1) levels in 82 non-pregnant pGDM and 113 control women without pGDM. A subgroup of 21 women, taken from the pGDM group, showing current normal BMI, and no metabolic abnormalities, was separately analysed. All the subjects were free of medication and non-smokers. Women with pGDM, independently by their current BMI and presence of metabolic abnormalities, showed significantly higher E-selectin, ICAM-1 and IMT values than controls. IMT proved to be significantly associated with pGDM in a regression model, after adjustments for BMI, waist circumference, blood pressure, and glucose values (beta=0.046; 95% CI 0.028-0.064). In all pGDM women, E-selectin, ICAM-1, IL-6 and hs-CRP values were significantly associated with IMT in the same model. Post-GDM women, despite being currently free from metabolic abnormalities, showed higher values of markers of endothelial dysfunction and IMT than controls, consistent with an increased future cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055515     DOI: 10.1016/j.atherosclerosis.2006.09.017

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  36 in total

1.  Asymmetric dimethylarginine is associated with high-sensitivity C-reactive protein and early carotid atherosclerosis in women with previous gestational diabetes mellitus.

Authors:  Wei Xia; Dajiang Li; Chunquan Zhang; Li Xu; Wenliang Xu; Yibing Shao
Journal:  Endocrine       Date:  2014-06-25       Impact factor: 3.633

2.  Hypertensive disorders during pregnancy and 3 years after delivery in women with gestational hyperglycemia.

Authors:  C Festa; L Mattei; O Bitterman; B Pintaudi; M Framarino Dei Malatesta; P Bianchi; M Trappolini; A Colatrella; A Napoli
Journal:  J Endocrinol Invest       Date:  2018-01-24       Impact factor: 4.256

3.  Vascular ultrasound measures before pregnancy and pregnancy complications: A prospective cohort study.

Authors:  Emily W Harville; Markus Juonala; Jorma S A Viikari; Mika Kähönen; Olli T Raitakari
Journal:  Hypertens Pregnancy       Date:  2016-11-18       Impact factor: 2.108

Review 4.  Gestational diabetes: implications for cardiovascular health.

Authors:  Shannon D Sullivan; Jason G Umans; Robert Ratner
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

5.  Gestational diabetes: pathogenesis and consequences to mother and offspring.

Authors:  Risto Kaaja; Tapani Rönnemaa
Journal:  Rev Diabet Stud       Date:  2009-02-10

6.  The possible role of epigenetics in gestational diabetes: cause, consequence, or both.

Authors:  J L Fernández-Morera; S Rodríguez-Rodero; E Menéndez-Torre; M F Fraga
Journal:  Obstet Gynecol Int       Date:  2010-10-31

7.  Alteration of endothelial function markers in women with gestational diabetes and their fetuses.

Authors:  Nicholas M Mordwinkin; Joseph G Ouzounian; Larisa Yedigarova; Martin N Montoro; Stan G Louie; Kathleen E Rodgers
Journal:  J Matern Fetal Neonatal Med       Date:  2012-11-09

Review 8.  Gestational diabetes, inflammation, and late vascular disease.

Authors:  L Volpe; G Di Cianni; C Lencioni; I Cuccuru; L Benzi; S Del Prato
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 9.  Late cardiovascular consequences of gestational diabetes mellitus.

Authors:  Rhonda Bentley-Lewis
Journal:  Semin Reprod Med       Date:  2009-06-15       Impact factor: 1.303

10.  Noninvasive assessment of subclinical atherosclerosis in normotensive gravidae with gestational diabetes.

Authors:  A E Atay; H Simsek; B Demir; M N Sakar; M Kaya; S Pasa; S Demir; D Sit
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.